ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Adrenergic syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
2,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
3,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
4,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
5,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
5,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
7,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
7,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
8,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
9,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
10,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
11,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
12,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
13,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
14,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
15,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
16,1,Abortion,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
17,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
17,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
18,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
19,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
20,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
21,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
21,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
22,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
22,2,Headache,Headaches NEC,Headaches,Nerv,N
22,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
23,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
23,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
23,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
24,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
25,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
26,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
26,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
27,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
28,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
29,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
30,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
31,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
32,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
33,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
34,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
35,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
36,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
37,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
38,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
38,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
38,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
40,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
41,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
41,2,Cancer surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
41,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
42,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
42,2,Radiation injury,Radiation injuries,Injuries by physical agents,Inj&P,N
43,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
43,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
43,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
43,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
44,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
44,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
45,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
45,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
46,1,Dissociation,Dissociative states,Dissociative disorders,Psych,N
47,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
49,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
49,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
50,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
50,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
51,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
51,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
52,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
53,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
54,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
54,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
55,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
55,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
56,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
56,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
57,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
57,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
58,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,2,Premature ejaculation,Orgasmic disorders and disturbances,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
58,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
59,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
60,1,Atypical femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
61,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
62,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
62,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
62,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
63,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
65,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
65,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
65,3,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
66,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
66,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
66,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
66,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
66,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
67,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
67,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
68,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
68,2,Hodgkin's disease recurrent,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,Y
68,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
68,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
69,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
69,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
70,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
71,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
71,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
71,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
71,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
71,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
72,1,Device related thrombosis,Vascular complications associated with device,Complications associated with device,Genrl,N
73,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
73,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
73,3,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
73,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
73,5,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
74,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
74,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
74,3,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
74,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
74,5,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
74,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
74,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
75,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
75,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
76,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
76,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
76,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
76,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
77,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
77,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
77,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
77,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
77,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
78,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
79,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
80,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
80,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
80,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
80,4,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
80,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
81,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
81,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
81,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
82,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
82,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
83,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
83,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
83,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
83,4,Nasal oedema,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
83,5,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
83,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
84,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
84,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
85,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
86,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
86,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
86,3,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
86,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
